Feedback: Merging the three tabs - “biomolecules”, “biomarkers”, “evidences” - in one would make it easier to follow.
Perhaps the cards that you have designed for the papers would be much better as biomarker cards.
In them you could have in the heading: Database ID, Gene ID, Name, Description (perhaps with link to DAVID or GeneCards or OMIM), Biomolecules (and there having a different symbol if present in DNA/RNA/protein form); and then once the readers click on the heading they get information on: which type of biomarker, samples, validated/non-validated, in clinical use or not, description of patient samples/cohorts in which it was discovered, description of controls, population, retrospective/prospective, references (here PMID number should be sufficient), etc.
I think it would be a much nicer overview if the biomarker cards are reported on the first page.
Feedback: Merging the three tabs - “biomolecules”, “biomarkers”, “evidences” - in one would make it easier to follow. Perhaps the cards that you have designed for the papers would be much better as biomarker cards. In them you could have in the heading: Database ID, Gene ID, Name, Description (perhaps with link to DAVID or GeneCards or OMIM), Biomolecules (and there having a different symbol if present in DNA/RNA/protein form); and then once the readers click on the heading they get information on: which type of biomarker, samples, validated/non-validated, in clinical use or not, description of patient samples/cohorts in which it was discovered, description of controls, population, retrospective/prospective, references (here PMID number should be sufficient), etc. I think it would be a much nicer overview if the biomarker cards are reported on the first page.